2016 Orthopedics Market Consolidation: Who will not survive?

October 2015 | 136 pages | ID: 2D2EA6ECD2AEN
Venture Planning Group

Abstracts

• Will the $50 billion global orthopedics industry consolidate, decentralize, or undergo a bimodal transformation?
• How will the current trends affect the major market segments?
• Which companies will enter the market and which will not survive?

Contents

I. MARKET OVERVIEW

a. U.S.A
  1. Business Environment
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Industry Consolidation
    d. Managed Care
    e. Hospitals
    f. Admissions
  g. Length of Stay
  h. Industry Diversification
  i. Physician Demographics
  j. Population Aging
b. Other Countries

II. MARKET SIZE AND GROWTH

a. Major Market Segments
b. Major Geographic Regions

III. EMERGING TECHNOLOGIES

a. Overview
b. Resorbables
c. Bone Substitutes
d. Osteoinductive Agents/Bone Graft Factors
e. Soft Tissue Repair And Replacement
f. Viscoelastics
g. Osteoporosis Therapies

IV. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS BUSINESS, NEW PRODUCT DEVELOPMENT AND MARKETING STRATEGIES

Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses

V. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS

The U.S. and international sales force size
Distribution approaches
Major promotional tactics

VI. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL

Know-How
Internally developed and acquired technologies
Technical expertise in biotechnology, engineering and other pertinent fields